Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-30

Clinical Trial Update: Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on ENT-01 for Parkinson's Disease-related constipation report safety and tolerability data from Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENT-01

Snippet

Sponsor: Enterin Inc. | Conditions: Parkinson's Disease, Constipation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-30